Β‑blockers Inhibit the Viability of Breast Cancer Cells by Regulating the ERK/COX‑2 Signaling Pathway and the Drug Response Is Affected by ADRB2 Single‑nucleotide Polymorphisms

Oncology Reports - Greece
doi 10.3892/or.2018.6830

Related search